Chemotherapy of the thyroid cancer

Uhlyarik Andrea (1), Petrányi Ágota (2), Rácz Károly (3), Bodoky György (2)
– (1) Magyar Honvédség Egészségügyi Központ, Budapest
– (2) Egyesített Szent István és Szent László Kórház, Onkológiai osztály, Budapest
– (3) Semmelweis Egyetem, II. Sz. Belgyógyászati Klinika, Budapest

The incidence of thyroid cancers increased signiﬁ cantly over the past few decades, but the mortality rate decreased. The clinical course and therapy for the three types of thyroid cancer (differentiated, medullary and anaplastic) are different. The medical therapy consists of levothyroxin therapy, conventional chemotherapeutic agents and tyrosin kinase inhibitors. The aim of this review is to summarize the therapeutic options of each histological subtype.